Orthoflex

Company Overview

Snapshot

Founded in January 2004 by Daniel Reis and Dalia Zucker, Orthoflex operates with 11–50 employees. The company holds one patent and has ceased operations as of July 2026.

Business overview

Orthoflex develops and produces a line of functional orthopedic braces, including light, easy-to-use, X-ray transparent, and sterilizable solutions. Their core products, such as the OF-1 foot and ankle brace, OF-2 long brace, and URIEL Ortho-Flex surgical sternum and rib belt, provide user-friendly support for temporary foot and ankle issues, and stabilize rib fractures and sternotomies through compression. The company serves markets within the Health Tech & Life Sciences sector, specifically focusing on medical devices and treatments for patients, providers, seniors, and military personnel.

Company Intelligence Q&A

What is Orthoflex's primary business?

Orthoflex develops and produces functional orthopedic braces, including solutions for foot and ankle support, and surgical sternum and rib stabilization.

When was Orthoflex founded and by whom?

Orthoflex was founded in January 2004 by Daniel Reis and Dalia Zucker.

What is the operational status of Orthoflex?

Orthoflex is currently non-active, having ceased operations in July 2026.

What are some of Orthoflex's key products?

Orthoflex's key products include the OF-1 foot and ankle brace, the OF-2 long brace, and the URIEL Ortho-Flex surgical sternum and rib belt.

In which sectors does Orthoflex primarily operate?

Orthoflex primarily operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics.